153 related articles for article (PubMed ID: 29937938)
21. Inhibition of MZF1/c-MYC Axis by Cantharidin Impairs Cell Proliferation in Glioblastoma.
Wang CH; Wu HC; Hsu CW; Chang YW; Ko CY; Hsu TI; Chuang JY; Tseng TH; Wang SM
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499054
[TBL] [Abstract][Full Text] [Related]
22. Preparation and pharmacological evaluation of norcantharidin-conjugated carboxymethyl chitosan in mice bearing hepatocellular carcinoma.
Jiang Z; Chi J; Han B; Liu W
Carbohydr Polym; 2017 Oct; 174():282-290. PubMed ID: 28821069
[TBL] [Abstract][Full Text] [Related]
23. Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells.
Chen YN; Chen JC; Yin SC; Wang GS; Tsauer W; Hsu SF; Hsu SL
Int J Cancer; 2002 Jul; 100(2):158-65. PubMed ID: 12115564
[TBL] [Abstract][Full Text] [Related]
24. FAM46C is critical for the anti-proliferation and pro-apoptotic effects of norcantharidin in hepatocellular carcinoma cells.
Zhang QY; Yue XQ; Jiang YP; Han T; Xin HL
Sci Rep; 2017 Mar; 7(1):396. PubMed ID: 28341836
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory effect of norcantharidin on K562 human myeloid leukemia cells in vitro.
Yi SN; Wass J; Vincent P; Iland H
Leuk Res; 1991; 15(10):883-6. PubMed ID: 1921448
[TBL] [Abstract][Full Text] [Related]
26. [Inhibitory effect of norcantharidin combined with evodiamine on the growth of human hepatic carcinoma cell line HepG2 in vitro].
Liu Y; Zahng J; You Z; Liao H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug; 30(8):824-8. PubMed ID: 25108435
[TBL] [Abstract][Full Text] [Related]
27. Cantharidin Impairs Cell Migration and Invasion of Human Lung Cancer NCI-H460 Cells via UPA and MAPK Signaling Pathways.
Hsia TC; Yu CC; Hsiao YT; Wu SH; Bau DT; Lu HF; Huang YP; Lin JG; Chang SJ; Chung JG
Anticancer Res; 2016 Nov; 36(11):5989-5997. PubMed ID: 27793925
[TBL] [Abstract][Full Text] [Related]
28. Norcantharidin Induces HL-60 Cells Apoptosis In Vitro.
Jiang YM; Meng ZZ; Yue GX; Chen JX
Evid Based Complement Alternat Med; 2012; 2012():154271. PubMed ID: 22778770
[TBL] [Abstract][Full Text] [Related]
29. Antimetastatic effects of norcantharidin on hepatocellular carcinoma cells by up-regulating FAM46C expression.
Wan XY; Zhai XF; Jiang YP; Han T; Zhang QY; Xin HL
Am J Transl Res; 2017; 9(1):155-166. PubMed ID: 28123642
[TBL] [Abstract][Full Text] [Related]
30. 18-GA-Suc Modified Liposome Loading Cantharidin for Augmenting Hepatic Specificity: Preparation, Characterization, Antitumor Effects, and Liver-Targeting Efficiency.
Zhu K; Zhou L; Zou M; Ning S; Liu S; Zhou Y; Du K; Zhang X; Xia X
J Pharm Sci; 2020 Jun; 109(6):2038-2047. PubMed ID: 32173319
[TBL] [Abstract][Full Text] [Related]
31. Cantharidin induces G2/M phase arrest by inhibition of Cdc25c and Cyclin A and triggers apoptosis through reactive oxygen species and the mitochondria‑dependent pathways of A375.S2 human melanoma cells.
Hsiao YP; Tsai CH; Wu PP; Hsu SC; Liu HC; Huang YP; Yang JH; Chung JG
Int J Oncol; 2014 Dec; 45(6):2393-402. PubMed ID: 25340978
[TBL] [Abstract][Full Text] [Related]
32. Norcantharidin inhibits pre-replicative complexes assembly of HepG2 cells.
Chen S; Qu X; Wan P; Li QW; Wang Z; Guo F; Bai L; Hu Z; Tan W; Li J
Am J Chin Med; 2013; 41(3):665-82. PubMed ID: 23711148
[TBL] [Abstract][Full Text] [Related]
33. Norcantharidin induces human melanoma A375-S2 cell apoptosis through mitochondrial and caspase pathways.
An WW; Wang MW; Tashiro S; Onodera S; Ikejima T
J Korean Med Sci; 2004 Aug; 19(4):560-6. PubMed ID: 15308848
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic effects of cantharidin analogues without bridging ether oxygen on human hepatocellular carcinoma cells.
Yeh CB; Su CJ; Hwang JM; Chou MC
Eur J Med Chem; 2010 Sep; 45(9):3981-5. PubMed ID: 20691337
[TBL] [Abstract][Full Text] [Related]
35. Norcantharidin inhibits growth of human gallbladder carcinoma xenografted tumors in nude mice by inducing apoptosis and blocking the cell cycle in vivo.
Fan YZ; Zhao ZM; Fu JY; Chen CQ; Sun W
Hepatobiliary Pancreat Dis Int; 2010 Aug; 9(4):414-22. PubMed ID: 20688607
[TBL] [Abstract][Full Text] [Related]
36. Folate receptor-targeted liposomes loaded with a diacid metabolite of norcantharidin enhance antitumor potency for H22 hepatocellular carcinoma both in vitro and in vivo.
Liu MC; Liu L; Wang XR; Shuai WP; Hu Y; Han M; Gao JQ
Int J Nanomedicine; 2016; 11():1395-412. PubMed ID: 27110110
[TBL] [Abstract][Full Text] [Related]
37. Norcantharidin-induced apoptosis in oral cancer cells is associated with an increase of proapoptotic to antiapoptotic protein ratio.
Kok SH; Cheng SJ; Hong CY; Lee JJ; Lin SK; Kuo YS; Chiang CP; Kuo MY
Cancer Lett; 2005 Jan; 217(1):43-52. PubMed ID: 15596295
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological mechanisms of norcantharidin against hepatocellular carcinoma.
Qian ZM; Chen YJ; Bao YX
Am J Cancer Res; 2023; 13(11):5024-5038. PubMed ID: 38058814
[TBL] [Abstract][Full Text] [Related]
39. Induction of apoptosis by norcantharidin in human colorectal carcinoma cell lines: involvement of the CD95 receptor/ligand.
Peng F; Wei YQ; Tian L; Yang L; Zhao X; Lu Y; Mao YQ; Kan B; Lei S; Wang GS; Jiang Y; Wang QR; Luo F; Zou LQ; Liu JY
J Cancer Res Clin Oncol; 2002 Apr; 128(4):223-30. PubMed ID: 11935314
[TBL] [Abstract][Full Text] [Related]
40. Development of 11-DGA-3-
Zhou L; Zou M; Zhu K; Ning S; Xia X
Molecules; 2019 Aug; 24(17):. PubMed ID: 31450608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
